Abstract:Blood is considered as the most valuable biofluid for protein biomarker screening as it contains a comprehensive human proteome, including cytokines and tissue leakage proteins that reflect ongoing disease states. Though widely used in large-scale protein quantification, mass spectrometry (MS)-based proteomic strategies still face great challenges in protein biomarker discovery in the blood, due to the particularly large dynamic range of proteins and the strong suppression effect by high-abundant proteins in the blood. As a promising alternative, nanomaterials enrichment-based protein corona strategy is highly efficient in increasing proteome coverage, but with the drawback of potentially disrupting the original protein concentration in the blood. Therefore, we proposed an ultrasensitive strategy that capable of enhancing mass spectrometry signals of the low abundant proteins/peptide to promote quantification of more than 2000 proteins at 288 SPD or 5000 plasma proteins at 36 SPD throughput from neat plasma without enrichment. Our strategy leverages the unique multiplexing properties of TMT labeling to sum the “total” MS1 signal of the same peptide from a boosting channel using nanomaterials enriched protein digests and the study channels using digests of neat plasma to trigger MS/MS fragmentation more efficiently and sensitively for low abundant protein identification, while the reporter ions provide quantitative information. In this way, in depth coverage of low abundant protein in neat plasma can be achieved without the risk of disrupting their original quantification. Accurate and reproducible quantification of plasma proteins with concentration down to low ng/L range was achieved, which is still rate in the field. Sensitive differentiation of plasma proteome characteristics among healthy individuals by this method indicated its potential in disease biomarker screening.

Genetic mapping of plasma proteome on brain structure

Proteomics Identification of Proteins in Human Cortex Using Multidimensional Separations and MALDI Tandem Mass Spectrometer

Quantitative trait loci mapping of the mouse plasma proteome (pQTL)

Mapping biological influences on the human plasma proteome beyond the genome

TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma

Genomic atlas of the human plasma proteome

Mapping the Human Plasma Proteome by SCX-LC-IMS-MS

Mapping the human brain proteome: opportunities, challenges, and clinical potential

A Proteomic Approach for Plasma Biomarker Discovery with 8-Plex Itraq Labeling and SCX-LC-MS/MS

Plasma proteomic associations with genetics and health in the UK Biobank

The genetic landscape of neuro-related proteins in human plasma

Plasma proteome analyses in individuals of European and African ancestry identify cis -pQTLs and models for proteome-wide association studies

Mechanistic insight into glioma through spatially multidimensional proteomics

Proteogenomic links to human metabolic diseases

Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders

A genetic and proteomic comparison of key AD biomarkers across tissues

Atlas of the Plasma Proteome in Health and Disease in 53,026 Adults

Human brain proteome-wide association study provides insights into the genetic components of protein abundance in obesity

scProAtlas: an atlas of multiplexed single-cell spatial proteomics imaging in human tissues

Proteome-scale tissue mapping using mass spectrometry based on label-free and multiplexed workflows

An Ultra-Deep Quantitative Plasma Proteomics Strategy